Freiburg im Breisgau, 13.03.2025 – ChemCon GmbH, a leading provider of pharmaceutical active ingredients and specialty chemicals, is pleased to announce its membership in the Federal Association of the Pharmaceutical Industry e.V. (BPI). This step strengthens ChemCon's commitment to the highest quality standards and its active involvement in shaping regulatory and economic frameworks in the pharmaceutical industry.
Through this membership, ChemCon aims to contribute to the interests of its region and industry. In addition, ChemCon will be able to intensify its exchange with other leading companies.
As a specialist in the manufacture of pharmaceutical active ingredients (APIs) under cGMP conditions, ChemCon supplies pharmaceutical companies worldwide with high-quality products that meet stringent regulatory requirements. The BPI membership will enable the company to engage even more closely in discussions about legislative developments and innovations in the future.
The BPI represents the interests of around 270 member companies along the entire pharmaceutical value chain and advocates for a forward-looking, patient-centered approach to drug supply. ChemCon shares these values and will actively participate in the working groups and technical committees of the association.
About ChemCon GmbH
ChemCon GmbH, headquartered in Freiburg im Breisgau, is a globally operating company specializing in the production of pharmaceutical active ingredients and specialty chemicals under cGMP conditions. With extensive experience in chemical synthesis and inorganic chemistry, ChemCon offers innovative solutions for the pharmaceutical industry, biotechnology, and related industries.
